According to a March 19 news release, the Tiger Tech COVID Plus Monitor will identify certain biomarkers that can be indicative of COVID-19 by using light sensors and a computer processor in an armband.
The sensor obtains pulsatile signals from blood flow, then extracts key features from those signals to make predictions on whether someone is showing signals common in COVID-19 patients, such as hypercoagulation in the blood.
The screening tool can be used in asymptomatic patients above the age of 5. It is not a COVID-19 diagnostic device and cannot be used on individuals with a fever.
More articles on artificial intelligence:
Machine learning tool can predict severe illness, death from COVID-19 in patients
AI could replicate, compound existing disparities in COVID-19 care, study finds
AI tool uses EHR data mining to support diagnostic decision-making
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.